Stereotactic radiotherapy using the CyberKnife is effective for local control of bone metastases from differentiated thyroid cancer.

Abstract

Differentiated thyroid cancer (DTC) is associated with a good long-term prognosis, but bone metastases can adversely affect patients' quality of life and survival. Stereotactic radiotherapy (SRT) can deliver high-dose irradiation to target lesions and it has been reported to be useful for various cancers. However, few studies have examined the efficacy of SRT for thyroid cancer. In the present study, the aim was to investigate the efficacy of SRT using the CyberKnife for bone metastases from DTC. From September 2013 to April 2018, SRT with the CyberKnife system was used to treat 60 bone metastases from DTC in 13 patients. The patients' medical records were retrospectively reviewed to obtain information about the adverse events associated with SRT. Of the 60 lesions, 40 could be evaluated by follow-up CT for therapeutic effectiveness, and the RECIST criteria were used to assess the response. The cancers were papillary cancer in 3 patients, follicular cancer in 9 and poorly differentiated cancer in 1. SRT was delivered in 1-10 fractions, with a median dose of 27 Gy (range, 8-48 Gy). Adverse events were infrequent and mild. The median follow-up of the 40 lesions was 11 (range, 2-56) months. The responses were partial response in 2 lesions, stable disease in 37 lesions and progressive disease in 1 lesion, with a 1-year local control rate of 97.1%. The present study showed that SRT using the CyberKnife system was a feasible and effective treatment for bone metastases of DTC.

• Authors: Takayuki Ishigaki, Takashi Uruno, Kiminori Sugino, Chie Masaki, Junko Akaishi, Kiyomi Y Hames, Akifumi Suzuki, Chisato Tomoda, Kenichi Matsuzu, Keiko Ohkuwa, Wataru Kitagawa, Mitsuji Nagahama, Shinichiro Miyazaki, Koichi Ito
• Journal: Journal of radiation research (J Radiat Res) Vol. 60 Issue 6 Pg. 831-836 (Nov 22 2019) ISSN: 1349-9157 [Electronic] England
• PMID: 31423531 (Publication Type: Journal Article)
• Copyright: © The Author(s) 2019. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.

Topics

• Adult
• Aged
• Aged, 80 and over
• Bone Neoplasms (diagnostic imaging, radiotherapy, secondary)
• Cell Differentiation
• Female
• Follow-Up Studies
• Humans
• Male
• Middle Aged
• Radiosurgery
• Survival Analysis
• Thyroid Neoplasms (diagnostic imaging, pathology)
• Tomography, X-Ray Computed
• Treatment Outcome